Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jul 16, 2025; 17(7): 108030
Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.108030
Published online Jul 16, 2025. doi: 10.4253/wjge.v17.i7.108030
Table 2 Reported outcomes of various options for the treatment of post-endoscopic retrograde cholangiopancreatography cholecystitis
Technique | Avoid in | Technical success (%) | Clinical success (%) | Adverse events (%) | Recurrence (%) |
Conservative | Moderate to severe cholangitis | - | 96 | - | - |
PTGBA | Severe cholangitis, tumor involvement of OCD | 100 | 54-90 | 0-7.1 | 14.3-36.7 |
PTGBD | Coagulopathy, ascites | 95-100 | 91-95 | 0-9 | 10-33 |
ETGBD | Complete cystic duct obstruction | 75-83.3 | 90-100 | 0-16.7 | 0 |
EUS-GBD | Coagulopathy | 90-100 | 89-100 | 8-40 | 0-38 |
Cholecystectomy | Critically ill patients | 100 | 100 | - | - |
- Citation: Giri S, Afzalpurkar S, Gore P, Khatana G, Sahu SK, Praharaj DL, Mallick B, Nath P, Sundaram S, Sahu MK. Post-endoscopic retrograde cholangiopancreatography cholecystitis: A review of incidence, risk factors, prevention, and management. World J Gastrointest Endosc 2025; 17(7): 108030
- URL: https://www.wjgnet.com/1948-5190/full/v17/i7/108030.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i7.108030